KalVista Pharmaceuticals, Inc.
KALV
$13.55
-$0.05-0.37%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 234.99% | 31.60% | 41.39% | 40.85% | -55.97% |
| Total Receivables | -60.30% | -39.30% | -40.24% | -41.69% | 86.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.68% | -13.83% | -15.73% | 2.58% | -37.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 156.82% | 18.40% | 27.89% | 30.97% | -45.82% |
|
|
|||||
| Total Current Assets | 156.82% | 18.40% | 27.89% | 30.97% | -45.82% |
| Net Property, Plant & Equipment | -23.46% | -19.37% | -23.35% | -15.07% | -14.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 249.37% | 96.44% | 470.75% | 434.91% | 101.52% |
| Total Assets | 142.17% | 15.92% | 24.86% | 28.49% | -43.99% |
|
|
|||||
| Total Accounts Payable | 88.84% | 6.17% | 113.28% | 89.06% | 82.63% |
| Total Accrued Expenses | 23.42% | 31.79% | 30.25% | 35.82% | 67.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.65% | 33.89% | 12.66% | 19.78% | 12.30% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.91% | 24.86% | 58.58% | 51.72% | 64.81% |
|
|
|||||
| Total Current Liabilities | 33.91% | 24.86% | 58.58% | 51.72% | 64.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.67% | -28.58% | -27.34% | -15.82% | -15.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 415.53% | 10.46% | 30.49% | 29.96% | 33.42% |
|
|
|||||
| Common Stock & APIC | 44.75% | 34.08% | 34.31% | 34.04% | 2.42% |
| Retained Earnings | -41.37% | -39.49% | -38.48% | -36.91% | -34.19% |
| Treasury Stock & Other | 32.97% | 22.05% | 0.76% | -13.99% | 6.98% |
| Total Common Equity | 63.83% | 17.08% | 24.02% | 28.29% | -51.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 63.83% | 17.08% | 24.02% | 28.29% | -51.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 63.83% | 17.08% | 24.02% | 28.29% | -51.97% |
|
|
|||||